Each year, the Conference on Retroviruses and Opportunistic Infections (CROI) unleashes a torrent of new HIV research, flooding the clinical science community with fresh data. Although this year's meeting, CROI 2021, was entirely virtual—and although the COVID-19 pandemic has upended so much of HIV research and clinical practice—it nonetheless brought us a new deluge of science, with hundreds of online presentations posted within the span of a week in early March.
For many of us who work in HIV care and services, a conference like CROI 2021 is far too massive in scope to browse all of the science ourselves. To filter out the essence of the most clinically relevant science, we need an expert hand to guide us.
That's why we hopped on a video call with David Alain Wohl, M.D., a leading HIV clinician-researcher and a professor of medicine in the Division of Infectious Diseases at the University of North Carolina-Chapel Hill. We asked Wohl to talk through some of the studies presented at CROI 2021 that he found most compelling—not merely from a pure data standpoint, but for the implications they have for the health care we'll provide to people living with or at risk for HIV in the weeks and months to come.
In this compilation of brief videos (each of which has a full transcript available), Wohl offers his expert analysis on each of the following topics:
- HIV, aging, cardiovascular disease, and hypertension
- Broadly neutralizing antibodies for COVID-19 and HIV
- COVID-19 susceptibility and severity in people living with HIV (PLWH)
- What's next for HIV pre-exposure prophylaxis (PrEP)
- Sleep, diet, and quality of life among PLWH
- The promise and perils of long-acting antiretroviral therapy